Oncology - European Medical Journal

Continue

Oncology

Filter
9 Mins
24 Nov 2017

Editor’s Pick: Simple, Low-Cost, and Timely Optical Biosensors for the Detection of Epigenetic Biomarkers: The Future of Cancer Diagnosis

The cancer burden continues to grow with enormous physical, emotional, and financial pressure on individuals, families, communities, and health systems.
9 Mins
24 Oct 2017

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer

Pancreatic cancer (PC) still represents an unresolved therapeutic challenge due to the associated poor prognosis and the lack of responsiveness to…
9 Mins
24 Oct 2017

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria

Radical prostatectomy is widely used as the primary modality of treatment for clinically localised prostate cancer.
9 Mins
24 Oct 2017

Prognostic and Predictive Value of FDG-PET as an Aid in Oesophageal Cancer Management

FDG-PET is widely used for cancer staging before treatment and detection of recurrence during post-treatment surveillance.
10 Mins
24 Oct 2017

Understanding the Microenvironment of Melanoma Cells for the Development of Target Drug Delivery Systems

Melanoma is the most aggressive and deadly form of skin cancer. The high rate of patient death is related to advanced melanoma metastasis, which usually…
10 Mins
24 Oct 2017

Chemotherapy for Extracranial Germ Cell Tumours in Paediatric, Adolescent, and Young Adult Patients

Extracranial germ cell tumours are derived from dysregulated, unipotent to totipotent, primordial germ cells and can arise from heterogeneous sites and…
9 Mins
24 Oct 2017

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

Pleural malignancies constitute either primary pleural malignancies, such as malignant pleural mesothelioma (MPM), or secondary pleural tumours, either…
3 Mins
12 Oct 2017

How to Play an Important Role in Raising Awareness for Mesothelioma in Health Education Week

Blue is the colour of hope that brings a broader awareness to a rare cancer called mesothelioma.